Rick Pauls
Overview
Rick Pauls received an average of $1M in total compensation, including $433K in salary, at DiaMedica Therapeutics from 2017 to 2023.
2023DiaMedica TherapeuticsPresident and Chief Executive Officer
2022DiaMedica TherapeuticsPresident and Chief Executive Officer
2021DiaMedica TherapeuticsPresident and Chief Executive Officer
2020DiaMedica TherapeuticsPresident and Chief Executive Officer
2019DiaMedica TherapeuticsPresident and Chief Executive Officer
2018DiaMedica TherapeuticsPresident and Chief Executive Officer
2017DiaMedica TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on April 4, 2024, April 4, 2023, April 5, 2022, April 20, 2020, and April 8, 2019.
Related executives
We found five more executives who work or worked at DiaMedica Therapeutics.
Scott Kellen
DiaMedica Therapeutics
Chief Financial Officer
Kirsten Gruis
DiaMedica Therapeutics
Chief Medical Officer
Julie Daves
DiaMedica Therapeutics
SVP, Clinical Development Operations
Harry Alcorn
DiaMedica Therapeutics
Senior Vice President of Clinical Operations
Todd Verdoorn
DiaMedica Therapeutics
Chief Scientific Officer
News
DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
April 4, 2024
DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
April 4, 2023
DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
April 5, 2022
DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
April 20, 2020
DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
April 8, 2019